Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

Source:http://linkedlifedata.com/resource/pubmed/id/10916759

Download in:

View as

General Info

PMID
10916759